INTERPACE BIOSCIENCES, INC. (IDXG) Financial Statements (2024 and earlier)

Company Profile

Business Address WATERVIEW PLAZA, SUITE 310
PARSIPPANY, NJ 07054
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,8283,0642,7722,3216,06815,199
Cash and cash equivalents4,8283,0642,7722,3216,06815,199
Restricted cash and investments  250    
Receivables5,0326,1588,02810,1979,4833,437
Inventory, net of allowances, customer advances and progress billings1,2241,7862,0521,825  
Inventory1,2241,7862,0521,825  
Other current assets2,2942,6942,7223,8512,1701,172
Other undisclosed current assets(1,224)(1,786)(1,452)(1,825)  
Total current assets:12,15412,16614,12216,36917,72119,808
Noncurrent Assets
Operating lease, right-of-use asset2,4394,0324,384 
Property, plant and equipment4806,3497,3496,814837654
Intangible assets, net (including goodwill)86115,72019,78441,93429,85333,105
Goodwill  8,4338,4338,433  
Intangible assets, net (excluding goodwill)8617,28711,35133,50129,85333,105
Other noncurrent assets4516042423131
Other undisclosed noncurrent assets    3,892  
Total noncurrent assets:3,82526,26131,55952,68230,72133,790
TOTAL ASSETS:15,97938,42745,68169,05148,44253,598
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10,92514,91617,4677,7537,5746,789
Taxes payable  403  
Employee-related liabilities3,0243,1612,3411,4241,394
Accounts payable1,0502,6944,5114,8121,059391
Accrued liabilities9,8759,1989,7951975,0915,004
Deferred revenue    457
Debt 578  1,505  
Disposal group, including discontinued operation8587667667669181,302
Business combination, contingent consideration, liability    502  
Due to related parties   888  
Other undisclosed current liabilities 1,922  5,427  
Total current liabilities:14,28315,68218,23317,2988,4928,091
Noncurrent Liabilities
Long-term debt and lease obligation, including:1,8483,2133,6782,714  
Long-term debt, excluding current maturities11,1657,942    
Finance lease, liability   138123
Other undisclosed long-term debt and lease obligation (9,317)(7,883)    
Liabilities, other than long-term debt, including:7,0676,0316,4556,9643,9584,289
Liability for uncertainty in income taxes     3,8383,734
Other liabilities4,7014,6484,6374,57312082
Operating lease, liability1,8483,1543,5402,591
Business combination, contingent consideration, liability 5181,3831,8182,391  
Other undisclosed liabilities, other than long-term debt      473
Other undisclosed noncurrent liabilities 9,3179,383(138)(5,105)3611,349
Total noncurrent liabilities:18,23218,6279,9954,5734,3195,638
Other undisclosed liabilities    7,9822,693 
Total liabilities:32,51534,30928,22829,85315,50413,729
Temporary equity, carrying amount46,53646,536 26,172  
Equity
Equity, attributable to parent(63,072)(42,418)(29,083)13,02632,93839,869
Common stock405403402393287278
Treasury stock, value(1,976)(1,868)(1,773)(1,721)(1,680)(1,671)
Additional paid in capital187,516186,106184,404182,514175,820173,062
Accumulated deficit(249,017)(227,059)(212,116)(168,160)(141,489)(131,800)
Other undisclosed equity   46,536   
Total equity:(63,072)(42,418)17,45313,02632,93839,869
TOTAL LIABILITIES AND EQUITY:15,97938,42745,68169,05148,44253,598

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues5,67841,31432,39824,07921,89615,897
Revenue, net15,897
Cost of revenue(13,607)(23,369)(21,673)(15,888)(10,197)(7,358)
Cost of goods and services sold     (10,197) 
Other undisclosed gross profit26,160     
Gross profit:18,23117,94510,7258,19111,6998,539
Operating expenses(21,848)(31,942)(36,791)(34,614)(23,818)(14,832)
Operating income (loss):(3,617)(13,997)(26,066)(26,423)(12,119)(6,293)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(1,211)(496)467196263(2,128)
Interest and debt expense  (920)(549)(440)(331)(4,711)
Loss from continuing operations before equity method investments, income taxes:(4,828)(15,413)(26,148)(26,667)(12,187)(13,132)
Other undisclosed loss from continuing operations before income taxes(1,008)     
Loss from continuing operations before income taxes:(5,836)(15,413)(26,148)(26,667)(12,187)(13,132)
Income tax expense (benefit)(29)667(53)28(18)395
Loss from continuing operations:(5,865)(14,746)(26,201)(26,639)(12,205)(12,737)
Loss before gain (loss) on sale of properties:(14,943)(26,451)(26,727)(12,189)(12,216)
Income (loss) from discontinued operations(16,093)(197)(250)(88)16521
Net loss attributable to parent:(21,958)(14,943)(26,451)(26,727)(12,189)(12,216)
Preferred stock dividends and other adjustments   (3,033)(429)  
Net loss available to common stockholders, diluted:(21,958)(14,943)(29,484)(27,156)(12,189)(12,216)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(21,958)(14,943)(26,451)(26,727)(12,189)(12,216)
Comprehensive loss, net of tax, attributable to parent:(21,958)(14,943)(26,451)(26,727)(12,189)(12,216)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: